Ando et al. (2015) showed that the use of α-GalCer in the treatment of a mice model of metastatic lung cancer increased the production of cytokine IFN-γ by spleen cells and the population of anti-tumor cell killer T cells [25]. Here, IFNG is linked to neoplasm.